Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A gynecologic oncology group study
- 1 January 1994
- Vol. 73 (1) , 196-199
- https://doi.org/10.1002/1097-0142(19940101)73:1<196::aid-cncr2820730134>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.Journal of Clinical Oncology, 1992
- Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.Proceedings of the National Academy of Sciences, 1991
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.Proceedings of the National Academy of Sciences, 1988
- Reversal of drug‐resistance in multiple myeloma with verapamilBritish Journal of Haematology, 1988
- Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell lineBritish Journal of Cancer, 1987
- Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinomaBritish Journal of Cancer, 1986
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986
- Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites CarcinomaJournal of Clinical Investigation, 1982